New Targets in Allergic Rhinitis Management

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology".

Deadline for manuscript submissions: closed (20 June 2021) | Viewed by 442

Special Issue Editor

E-Mail Website
Guest Editor
Department of Internal Medicine, University of Verona, 37100 Verona, Italy
Interests: allergic rhinitis; asthma; antihistamines; nasal steroids; complementary medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Allergic rhinitis is still considered a trivial disease, though it affects more than 70 million people in Europe. Self-diagnosis and self-treatment are very common, leading to poor control of the disease. To note, in addition to the well-known clinical picture characterized by sneezing and rhinorrhea, nasal obstruction is responsible for sleep impairment as well as for drowsiness during the day, which can negatively affect driving ability, working capacity, and quality of life.

Although the currently available drugs and treatment are very effective and safe and can achieve a satisfying control in most cases, patients frequently do not receive medical advice or are not adherent to prescriptions. Therefore, the disease is still uncontrolled in many cases. Concomitant asthma and the complex relationships between upper and lower airways also need to be pointed out.

Dr. Gianenrico Senna
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • rhinitis
  • asthma
  • antihistamines
  • allergen immunotherapy
  • complementary medicine

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop